Medication
Apo-Montelukast
DIN 02374609 · Apotex Inc Likely a generic
What it is
- Active ingredients
- Montelukast — 10 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2012-01-20
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Singulair
- Sandoz Montelukast
- Teva-Montelukast
- PMS-Montelukast FC
- Ach-Montelukast
- Montelukast
- Montelukast
- Montelukast
- SPC-Montelukast
- Jamp-Montelukast
- Riva-Montelukast FC
- Mar-Montelukast
- Auro-Montelukast
- Mint-Montelukast
- Bio-Montelukast
- AG-Montelukast
- M-Montelukast
- Nra-Montelukast
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Respiratory system
- ATC code
- R03DC03
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of R03DC03, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.